Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients. [electronic resource]
Producer: 20200213Description: 606-610 p. digitalISSN:- 1531-8249
- Adult
- Biomarkers -- blood
- Cohort Studies
- Europe -- epidemiology
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- therapeutic use
- Leukoencephalopathy, Progressive Multifocal -- blood
- Male
- Middle Aged
- Multiple Sclerosis -- blood
- Natalizumab -- therapeutic use
- Neurofilament Proteins -- blood
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.